
|Videos|June 28, 2021
Ideal Candidates for Factor VIII and Emicizumab for Hemophilia A
Robert Sidonio, Jr., MD, MSc, discusses treatment considerations and ideal candidates for factor VIII and emicizumab in patients with hemophilia A.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Single-Center Experience With Vorasidenib in Patients With Grade 3 or 4 IDH-Mutant Gliomas
2
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence
3
Outcomes of Older Patients on Enfortumab Vedotin for Urothelial Carcinoma
4
McKesson ideaShare 2026: Why Automation and AI Are Reshaping the Dispensing Experience
5




















































































































